Aussies Chalmers, Titmus, Larkin & the Campbells Headline Swim Stars in ISL
Australian stars Kyle Chalmers, Cate and Bronte Campbell, Ariarne Titmus and Mitch Larkin will compete in a new professional league pitting the world’s best swimmers against each other in a revolutionary club-based competition, which will be shown exclusively live in Australia on 7plus.
The International Swimming League (ISL) will hold its inaugural meet in Indianapolis next month, when eight teams – four from the United States and four from Europe – will compete over two days in a full program of events over 50m to 400m.
This will be the first of seven ISL meets across the United States and Europe in 2019, with the top four teams qualifying for the final in Las Vegas in December.
With more than $5 million in prize money at stake, and most of swimming’s current Olympic champions and world-record holders set to take part, the competition will be fierce and is bound to showcase many of the captivating rivalries expected to take centre stage at the Olympic Games Tokyo 2020.
The international big names competing include Titmus’ great rival Katie Ledecky and fellow giants of the pool Adam Peaty, Sarah Sjostrom, Ryan Murphy, Federica Pellegrini, Chad le Clos and Nathan Adrian.
The Aussie contingent taking part also includes Emma McKeon, Cam McEvoy, Emily Seebohm, Clyde Lewis, Jess Hansen and Holly Barratt, giving swimming fans a chance like never before to track the progress of our brightest Olympic Games medal hopes as Tokyo 2020 draws ever closer.
Seven’s Head of Sport Saul Shtein said: “The ISL will give swimming an established place in the annual sporting calendar and offers sports fans the chance to watch the world’s best compete regularly in an exciting new format, while this inaugural season should also provide a tantalising lead-in to Tokyo 2020. We’re thrilled to bring it to our viewers and to be adding more premium live content to 7plus.”
Kontantin Grigorishin, ISL President, declared: "We are very excited about this partnership with Seven Sport, which will allow millions of fans in Australia to experience full live coverage of International Swimming League. The heart of swimming beats in Australia and will beat even stronger from October 6 with the first ever match of ISL in Indianapolis."
Swimming fans will also be able to watch highlights of every ISL meet on 7TWO and 7plus.
In 2020, Seven is the home of the Australian swimming Olympic Games trials and Tokyo 2020.
TV Broadcast times: October 6-7 ISL – Group A: Match 1 Indianapolis, USA Sydney 5.00am LIVE on 7plus Melbourne 5.00am LIVE on 7plus Brisbane 5.00am LIVE on 7plus Adelaide 4.30am LIVE on 7plus Perth 3.00am LIVE on 7plus
October 13-14 ISL – Group A: Match 2 Naples, Italy Sydney 4.00am LIVE on 7plus Melbourne 4.00am LIVE on 7plus Brisbane 3.00am LIVE on 7plus Adelaide 3.30am LIVE on 7plus Perth 1.00am LIVE on 7plus
October 20-21 ISL – Group B: Match 1 Dallas, USA Sydney 6.00am LIVE on 7plus Melbourne 6.00am LIVE on 7plus Brisbane 5.00am LIVE on 7plus Adelaide 5.30am LIVE on 7plus Perth 3.00am LIVE on 7plus
October 27-28 ISL – Group B: Match 2 Budapest, Hungary Sydney 4.00am LIVE on 7plus Melbourne 4.00am LIVE on 7plus Brisbane 3.00am LIVE on 7plus Adelaide 3.30am LIVE on 7plus Perth 1.00am LIVE on 7plus
November 17-18 ISL – USA Derby Washington DC, USA Sydney 6.00am LIVE on 7plus Melbourne 6.00am LIVE on 7plus Brisbane 5.00am LIVE on 7plus Adelaide 5.30am LIVE on 7plus Perth 3.00am LIVE on 7plus
November 24-25 ISL – Europe Derby London, UK Sydney 4.00am LIVE on 7plus Melbourne 4.00am LIVE on 7plus Brisbane 3.00am LIVE on 7plus Adelaide 3.30am LIVE on 7plus Perth 1.00am LIVE on 7plus
December 21-22 ISL – Final Las Vegas, USA TBC
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190910005683/en/
Contact information
Nick Bowen
0438 777 459.
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
MOPIC Unveils 32-Inch Autostereoscopic 3D Display for Endoscopic and Microscope Applications Capable of Realistic Depth and Immersive Visualization29.10.2025 10:00:00 EET | Press release
MOPIC, a leading developer of autostereoscopic 3D display technology, has unveiled its 32-inch autostereoscopic 3D display designed for 3D endoscopic and microscope imaging systems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251029144650/en/ MOPIC unveiled its 32-inch autostereoscopic 3D display capable of lifelike depth and spatial perception without the need for 3D glasses (Photo: MOPIC) The new product reproduces lifelike depth and spatial perception without the need for 3D glasses, setting a new benchmark for medical visualization and education. Optimized 3D Solution for Medical Training and Research The 32-inch autostereoscopic 3D display combines a display with an integrated 3D lens, an eye-tracking camera, and real-time 3D rendering software provided as an SDK. It supports standard stereo formats such as Side-by-Side, and can be directly connected to existing endoscopes or microscope systems through 3D software in
NEC to Acquire CSG, Strengthening Its Position as a Global Leader in Digital Transformation29.10.2025 09:44:00 EET | Press release
NEC Corporation (TSE: 6701) (“NEC”) and CSG Systems International, Inc. (NASDAQ: CSGS) (“CSG”) today announced they have entered into a definitive agreement under which NEC will acquire CSG for US$80.70 per share in cash, for a total enterprise value of approximately US$2.9 billion, or JPY438.5 billion, including debt. The transaction price represents a 17.38% premium over CSG’s closing price of US$68.75 on October 28, 2025, and a 23.07% premium to the volume-weighted average price (VWAP) of CSG common stock for the 30 days ending October 28, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251029203825/en/ The transaction strengthens NEC's position as a leader in next-generation digital solutions and accelerates AI and cloud-driven innovation for customers across industries. It will bring together complementary software and services across digital transformation, expanding NEC's software-as-a-service (SaaS) portfolio, c
Recover™ Secures Multi-Year Recycled Cotton Agreement with H&M29.10.2025 09:00:00 EET | Press release
Since early 2024, H&M and Recover™ have collaborated on product development, which now enables scaled commercial introduction of Recover™ mechanically recycled cotton into H&M’s collections. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251029456063/en/ Recover™ has signed a multi-year agreement with H&M to support the integration of its recycled cotton fiber, RCotton, for use in H&M’s products. Recover™ combines more than 75 years of textile recycling expertise with advanced processes that deliver traceability and consistent quality at an industrial scale, operating five recycling hubs located at the heart of textile production streams in Europe, Asia and the Americas. These capabilities are essential for a global fashion player like H&M Group, where transparency, fiber performance, and reliable supply are crucial to integrating recycled materials. “We are proud to enter into this partnership with H&M Group. Reliable acces
Samsung Bioepis to Commercialize BYOOVIZ ® (ranibizumab) in Europe from January 202629.10.2025 09:00:00 EET | Press release
Samsung Bioepis Co., Ltd. announced today that the company has entered into an Asset Purchase Agreement (APA) with Biogen regarding Samsung Bioepis’ two ophthalmology assets: BYOOVIZ® (ranibizumab), a biosimilar referencing Lucentisi (ranibizumab) and OPUVIZ™ (aflibercept), a biosimilar referencing Eyleaii (aflibercept) — in Europe. Samsung Bioepis will have full responsibility for commercialization of BYOOVIZ upon the transfer of commercial rights from Biogen back to Samsung Bioepis, effective as of January 2026. “We are pleased to announce our direct commercialization initiative for BYOOVIZ in Europe. We will work closely with Biogen to ensure a seamless transition and the continued delivery of services to our customers and patients in Europe,” said Linda Choi MacDonald, Executive Vice President and Global Head of Commercial, at Samsung Bioepis. “Samsung Bioepis will continue to broaden our reach to patients across Europe by reinforcing our leadership and expertise in biosimilars.” B
Ant Group’s AQ Tops China’s AI-Native Healthcare Apps, Launching New Features for Chronic Disease and Elderly Care29.10.2025 08:28:00 EET | Press release
Ant Group’s AI healthcare service AQ is now among China’s top 7 AI-native apps and the only healthcare app on the list, based on monthly active users, according to the latest report from QuestMobile on AI applications in China. Within this group, AQ achieved the highest compound growth rate of 83.4%. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251028871468/en/ Ant Group’s AI healthcare platform AQ introduces new features, including family health record sharing, to support chronic disease management and elderly care. Since its public beta as an Alipay mini-program in September 2024 and official launch as an independent app in China in June 2025, the AQ platform has served 140 million users as of September 2025. It provides more than 100 AI-powered services, including doctor recommendations, medical report analysis, and personalized health guidance. These developments come amid China’s ongoing demographic transformation. By
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom